Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene
Sign Up to like & getrecommendations! Published in 2019 at "Acta Haematologica"
DOI: 10.1159/000495687
Abstract: Background: The WHO defined myeloid and lymphoid neoplasms (MLN) with eosinophilia associated with PDGFRB, PDGFRA, FGFR1 rearrangements as a new entity in 2016. PDGFRB-rearranged MLN sensitive to imatinib were described in adult patients. We report… read more here.
Keywords: response; pdgfrb fusion; ccdc88c pdgfrb; lymphoblastic lymphoma ... See more keywords